1.
|
Phase: Phase II, Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000534115, P30CA014520, WCCC-CO05186, WCCC-H2006-0255, WCCC-06-1270-02, UWI05-7-01, NCT00450229
|
|
2.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Temporarily closed Age: 18 and over Sponsor: NCI, Other Protocol IDs: 2011-111, NCT01612910
|
|
3.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI, Other Protocol IDs: CDR0000462637, P30CA022453, WSU-D-2979, WSU-0507002581, NCT00305747
|
|
4.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Completed Age: 18 to 70 Sponsor: NCI, Other Protocol IDs: 9139, KUMC-HSC-9139-3, HSC # 9139, NCT00392652
|
|
5.
|
Phase: Phase I Type: Biomarker/Laboratory analysis, Prevention Status: Closed Age: 18 to 70 Sponsor: NCI, Other Protocol IDs: CDR0000617334, KUMC-HSC-9139, HSC# 9139, N01-CN-35008-1, NCT00784394
|